title: The hypertensive psychiatric patient: pharmacologic problems.
abstract: Psychiatric symptoms secondary to antihypertensive drugs and adverse drug interactions between antihypertensive and psychotropic drugs are described. Recommendations are made concerning the drug therapy of the hypertensive psychiatric patient.
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects*; D003000:Clonidine / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D006145:Guanethidine / Q000009:adverse effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008094:Lithium / Q000378:metabolism; D001523:Mental Disorders / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D008750:Methyldopa / Q000009:adverse effects; D011433:Propranolol / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012110:Reserpine / Q000009:adverse effects
chemical_list: D000959:Antihypertensive Agents; D004232:Diuretics; D011619:Psychotropic Drugs; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D008094:Lithium; D011433:Propranolol; D003000:Clonidine; D006145:Guanethidine